Kimberli Brill

Kimberli Brill has over 20 years of experience in the pharmaceutical industry. Kimberli is currently the Vice President of Clinical Sciences at Tallac Therapeutics, a position they have held since May 2023. Before that, they were the Executive Director of Clinical Sciences at Prelude Therapeutics for over a year. From 2020 to 2022, they worked at Pfizer as a Senior Director in Oncology Clinical Lead. Prior to that, they were a Senior Director of Clinical Research Scientist at Array BioPharma, Inc. from 2018 to 2020. Kimberli had a long tenure of 6 years as an Executive Director of Clinical Research Scientist at Incyte from 2012 to 2018. Before that, they held various roles, including the Director of Project Management at ICON Clinical Research and the Associate Director of Clinical Development at Ascenta Therapeutics, Inc. Kimberli started their career as a Clinical Project Manager at Imclone Systems Incorporated in 2001. Brill's experience spans across the pharmaceutical industry, including clinical sciences, research, and project management.

Kimberli Brill earned their Bachelor of Science degree in Nursing from The College of New Jersey in 1999. No other educational experiences are provided.